NCT00004794View on ClinicalTrials.gov

Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis

PHASE2CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

March 31, 1995

Conditions

Cytomegalovirus RetinitisAcquired Immunodeficiency Syndrome

Interventions

DRUG

cidofovir

All Listed Sponsors

collaborator

Northwestern University

OTHER

lead

National Center for Research Resources (NCRR)

NIH